Cargando…

Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib

Detalles Bibliográficos
Autores principales: Alharbi, Musa, Mobark, Nahla Ali, Balbaid, Ali Abdullah O., Alanazi, Fatmah A., Aljabarat, Wael abdel Rahman, Bakhsh, Eman A., Ramkissoon, Shakti H., Abedalthagafi, Malak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446437/
https://www.ncbi.nlm.nih.gov/pubmed/32923892
http://dx.doi.org/10.1200/PO.20.00017
_version_ 1783574147123642368
author Alharbi, Musa
Mobark, Nahla Ali
Balbaid, Ali Abdullah O.
Alanazi, Fatmah A.
Aljabarat, Wael abdel Rahman
Bakhsh, Eman A.
Ramkissoon, Shakti H.
Abedalthagafi, Malak
author_facet Alharbi, Musa
Mobark, Nahla Ali
Balbaid, Ali Abdullah O.
Alanazi, Fatmah A.
Aljabarat, Wael abdel Rahman
Bakhsh, Eman A.
Ramkissoon, Shakti H.
Abedalthagafi, Malak
author_sort Alharbi, Musa
collection PubMed
description
format Online
Article
Text
id pubmed-7446437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74464372020-09-30 Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib Alharbi, Musa Mobark, Nahla Ali Balbaid, Ali Abdullah O. Alanazi, Fatmah A. Aljabarat, Wael abdel Rahman Bakhsh, Eman A. Ramkissoon, Shakti H. Abedalthagafi, Malak JCO Precis Oncol Case Reports American Society of Clinical Oncology 2020-06-30 /pmc/articles/PMC7446437/ /pubmed/32923892 http://dx.doi.org/10.1200/PO.20.00017 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Case Reports
Alharbi, Musa
Mobark, Nahla Ali
Balbaid, Ali Abdullah O.
Alanazi, Fatmah A.
Aljabarat, Wael abdel Rahman
Bakhsh, Eman A.
Ramkissoon, Shakti H.
Abedalthagafi, Malak
Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title_full Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title_fullStr Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title_full_unstemmed Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title_short Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
title_sort regression of etv6-ntrk3 infantile glioblastoma after first-line treatment with larotrectinib
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446437/
https://www.ncbi.nlm.nih.gov/pubmed/32923892
http://dx.doi.org/10.1200/PO.20.00017
work_keys_str_mv AT alharbimusa regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT mobarknahlaali regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT balbaidaliabdullaho regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT alanazifatmaha regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT aljabaratwaelabdelrahman regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT bakhshemana regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT ramkissoonshaktih regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib
AT abedalthagafimalak regressionofetv6ntrk3infantileglioblastomaafterfirstlinetreatmentwithlarotrectinib